Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT00087802
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed, Stage IIIb or IV NSCLC, chemo or other systemic therapy naive
* One (1) unidimensionally measurable lesion
* ECOG Performance Status of 0 or 1, no peripheral neuropathy \>Grade 1
* Patients with clinically stable brain metastases on a stable dose of (or no longer requiring) dexamethasone at registration will be eligible. Patients who have received cranial radiation for brain metastases must be at least 4 weeks from last radiation treatment.
* Recovery in full from any previous surgical procedure
* No history of an acute cardiac or CNS event within 6 months of entry or current clinical evidence of congestive heart failure or non-stable coronary artery disease
Exclusion Criteria:
* Hypersensitivity to any of the 4 study drugs
* Concurrent immunotherapy or participation in any investigational drug study within 4 weeks
* Serious uncontrolled intercurrent medical or psychiatric illness and organ allograft
* History of other malignancy within the last 5 years (except for squamous or basal cell carcinoma of the skin, carcinoma in situ of the cervix, or superficial transitional cell carcinoma of the bladder)
* Patient is a pregnant or lactating female
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00087802
Study Brief:
Protocol Section:
NCT00087802